Showing 5,941 - 5,960 results of 17,305 for search '(( 5 ((ng decrease) OR (nn decrease)) ) OR ( 50 ((teer decrease) OR (a decrease)) ))', query time: 0.48s Refine Results
  1. 5941

    The top 10 active ingredients. by Lefei Yu (12274846)

    Published 2025
    “…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
  2. 5942
  3. 5943

    The flow chart. by Lefei Yu (12274846)

    Published 2025
    “…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
  4. 5944

    The active ingredients in RB-HMM. by Lefei Yu (12274846)

    Published 2025
    “…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
  5. 5945

    Physiologic values. by Hiroki Iwata (2434012)

    Published 2023
    “…The serum syndecan-1 concentration, a glycocalyx component, in the 4% hydrogen group (5.7 ± 4.4 pg/mL) was lower than in the control (19.5 ± 6.6 pg/mL) and 2% hydrogen (19.8 ± 5.0 pg/mL) groups (<i>P</i> < 0.001 for each), but it was not significantly different from the sham group (6.2 ± 4.0 pg/mL, <i>P</i> = 0.999). …”
  6. 5946

    Effects of the transobturator tape procedure on overactive bladder symptoms and quality of life: a prospective study by Salih Polat (8185269)

    Published 2019
    “…Conclusions: MUS is not only a gold standard treatment in SUI but also presents as a promising treatment modality in stress-dominant MUI. …”
  7. 5947

    Synthesis and Preclinical Validation of Novel Indole Derivatives as a GPR17 Agonist for Glioblastoma Treatment by Phung Nguyen (230474)

    Published 2021
    “…The <b>CHBC</b>–GPR17 interaction leads to a rapid decrease of cAMP and Ca<sup>2+</sup>. <b>CHBC</b> exhibits the cytotoxicity effect on GBM cells in a dose-dependent manner with an IC<sub>50</sub> of 85 μM, whereas the known agonist MDL29,951 showed a negligible effect. …”
  8. 5948

    Glyphosate alters the composition, but not density, of the <i>A</i>. <i>gambiae</i> midgut microbiota. by Daniel F. Q. Smith (10788903)

    Published 2021
    “…<p>(<b>A)</b> Glyphosate does not alter microbial density of the culturable mosquito midgut bacteria (grown on LB agar). …”
  9. 5949

    Disease course of Chronic Relapsing Inflammatory Optic Neuropathy (CRION) in a single care center by Luis Enrique MOLINA-CARRIÓN (12687286)

    Published 2022
    “…Currently, all patients are on maintenance treatment with mycophenolate mofetil or rituximab with a decrease in relapsing rate. Conclusions: Diagnosis of CRION is challenging and should be kept in mind. …”
  10. 5950
  11. 5951

    Table_1_Chemical-Shift-Encoded Magnetic Resonance Imaging and Spectroscopy to Reveal Immediate and Long-Term Multi-Organs Composition Changes of a 14-Days Periodic Fasting Interven... by Magalie Viallon (3140223)

    Published 2019
    “…Fat fraction, MRI relativity index T2<sup>*</sup> and susceptibility (Chi), as well as Fatty acid composition, were calculated at all-time points.</p><p>Results: A decrease in body weight (BW: −9.5%), quadriceps muscle volume (−3.2%), Subcutaneous and Visceral Adipose Tissue (SAT −34.4%; VAT −20.8%), liver fat fraction (PDFF = 1.4 vs. 2.6 % at baseline) but increase in Spine Bone Marrow adipose tissue (BMAT) associated with a 10% increase in global adiposity fraction (PDFF: 54.4 vs. 50.9%) was observed. …”
  12. 5952
  13. 5953
  14. 5954
  15. 5955
  16. 5956

    <b>Warming alters plankton body-size distributions in a large field experiment</b> by Dania Albini (20288463)

    Published 2024
    “…These samples were then brought to the lab, sieved and preserved in 70% Ethanol for a final volume of 50mL, in preparation for measurement and enumeration.…”
  17. 5957

    Table_1_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX by Phillip E. Vlisides (6740489)

    Published 2019
    “…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
  18. 5958

    Table_2_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX by Phillip E. Vlisides (6740489)

    Published 2019
    “…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
  19. 5959

    Image_1_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.pdf by Phillip E. Vlisides (6740489)

    Published 2019
    “…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
  20. 5960

    Table_4_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX by Phillip E. Vlisides (6740489)

    Published 2019
    “…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”